Abstract Approximately 70‐75% of women will have vulvovaginal candidosis (VVC) at least
once in their lifetime. In premenopausal, pregnant, asymptomatic and healthy women and …

An increasing number of people is affected by fungal biofilm-based infections, which are
resistant to the majority of currently-used antifungal drugs. Such infections are often caused …

The purpose of this study is to reveal the chemical and biochemical characteristics and the
potential aromatherapy applications of the essential oil (EO) of Salvia officinalis (common …

Vulvovaginal candidiasis (VVC) is the second most common vaginal infection that affects
women of reproductive age. Its increased occurrence and associated treatment cost coupled …

Vulvovaginal candidiasis (VVC) is a widely spread fungal infection that causes itching, pain
and inflammation at the vaginal site. Although common, currently available treatment suffers …

Vaginitis is a common problem in women. Candida albicans is responsible for more than
85% of vaginal fungal infections. The aim of this study was to compare the effects of probiotic …

Objectives: Identify clinical manifestations and risk factors associated with vaginal
candidiasis for accurate diagnosis. Differentiate vaginal candidiasis from other vaginal …

Candida albicans-mediated vulvovaginal candidiasis (VVC) is a significant challenge in
clinical settings, owing to the inefficacy of current antifungals in modulating virulence …

Purpose To compare the clinical response, microscopic examination and fungal culture
between dequalinium chloride (DQC) and clotrimazole (CT) for treating vaginal candidiasis …

BACKGROUND Candida vulvovaginitis is one of the most common infections of the female
at reproductive age that affects the quality of their life. Antifungal effects of honey, yogurt and …